Natural history of weight changes in pancreatic cancer: A longitudinal analysis.

A Aynur Aktas (Department of Supportive Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC) Y Ye Myint Aung (Department of Supportive Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC) B Brandon N. VanderVeen K Kunal C. Kadakia (Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Charlotte, NC) D Danielle Boselli (3Wake Forest University School of Medicine, Atrium Health Levine Cancer, Department of Cancer Biostatistics, Charlotte, United States) W Wael Lasheen (Atrium Health, Charlotte, NC) R Rupali Bose (1Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, United States) H Hang Zeng (1Atrium Health, Levine Cancer Institute, Charlotte, United States) H Hallie Millard (Atrium Health Levine Cancer Institute, Charlotte, NC) D Declan Walsh

Abstract

e24063 Background: Unintentional weight loss is common in people with pancreatic cancer and predicts poor outcomes. This study characterized temporal patterns of weight change following a pancreatic cancer diagnosis in a large, diverse patient population in a community oncology setting. Methods: Adults diagnosed with stage I–IV pancreatic cancer from 2020–2024 were identified from an internal registry. Longitudinal weights from six months prior to and 18 months after diagnosis were extracted from electronic medical records (EPIC). Among 635 eligible patients, 402 had baseline weights within one week of diagnosis. Percent weight change from diagnosis was modeled with separate pre- and post-diagnosis slopes, adjusted for age, sex, and stage, with patient-level random effects. Kaplan-Meier methods estimated length of follow-up and landmark overall survival. P<0.05 was considered statistically significant. Results: Median age was 69 (range 34-93) years; 48% were female, 71% White and non- Hispanic/Latino (98%). 52% had stage IV disease. Weight declined by 0.57% (95% CI, −0.64 to −0.49) per week before diagnosis and 0.28% (95% CI, −0.32 to −0.22) per week after diagnosis. Mean cumulative change was +14.7% (95% CI, +12.9% to +16.5%) at six months pre-diagnosis, +7.3% (95% CI, +6.5% to +8.2%) at 3 months pre-diagnosis, -3.6% (95% CI, -4.2% to -2.9%) at 3 months post-diagnosis, -7.1% (95% CI, -8.4% to -5.9%) at 6 months post-diagnosis, and -14.3% (95% CI, -16.7% to -11.9%) at 12 months post-diagnosis. Median follow-up was 19.6 months; 225 deaths (56%) occurred. One- and two-year survival rates were 0.53 and 0.34, respectively. Conclusions: Weight loss began up to six months before diagnosis and persisted afterward, averaging a 14% reduction within a year. These findings highlight the need for nutritional intervention at diagnosis and demonstrates the value of consistent and longitudinal weight management to identify at risk for future severe weight loss.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (10)

A

Aynur Aktas

Department of Supportive Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC

Y

Ye Myint Aung

Department of Supportive Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC

B

Brandon N. VanderVeen

K

Kunal C. Kadakia

Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Charlotte, NC

D

Danielle Boselli

3Wake Forest University School of Medicine, Atrium Health Levine Cancer, Department of Cancer Biostatistics, Charlotte, United States

W

Wael Lasheen

Atrium Health, Charlotte, NC

R

Rupali Bose

1Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, United States

H

Hang Zeng

1Atrium Health, Levine Cancer Institute, Charlotte, United States

H

Hallie Millard

Atrium Health Levine Cancer Institute, Charlotte, NC

D

Declan Walsh